Atara enlists Juno co-founder Michel Sadelain in CAR-T effort; Valeant no more, Bausch is the new marquee name
→ The day after Atara announced that it is bringing Genentech vet Dietmar Berger on board as R&D chief, the biotech is back with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
